Valion Bio (VBIO) Cash & Equivalents (2021 - 2026)
Valion Bio (VBIO) recorded Cash & Equivalents of $2.11 million in Q2 2026, up 78.0% from $1.18 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio reported Cash & Equivalents of $12.65 million, up 531.6% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of -0.6% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $2 million in FY2024 (-41.0%), $3.4 million in FY2023 (-3.5%), $3.52 million in FY2022 (-72.9%) and $12.98 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $700,000 in Q1 2025 to $12.98 million in Q4 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with growth averaging 63.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 531.6% in Q4 2025, against a decline of 72.9% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | 2.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Mn |
| Dec 31, 2025 | 12.65 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 5.20 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Jun 30, 2022 | 9.05 Mn |
| Mar 31, 2022 | 10.80 Mn |
| Dec 31, 2021 | 12.98 Mn |
API Access
Valion Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();